Innospec (IOSP) to Release Quarterly Earnings on Tuesday

Innospec (NASDAQ:IOSP) will announce its earnings results after the market closes on Tuesday, February 13th. Analysts expect the company to announce earnings of $1.17 per share for the quarter.

Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, November 7th. The specialty chemicals company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.15. Innospec had a net margin of 7.45% and a return on equity of 15.05%. The business had revenue of $332.40 million during the quarter, compared to the consensus estimate of $309.40 million. During the same quarter last year, the firm earned $0.78 earnings per share. Innospec’s quarterly revenue was up 61.8% on a year-over-year basis. On average, analysts expect Innospec to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Innospec (IOSP) opened at $66.10 on Tuesday. Innospec has a 52 week low of $54.10 and a 52 week high of $74.75. The firm has a market cap of $1,676.35, a price-to-earnings ratio of 18.31 and a beta of 1.07. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.35 and a current ratio of 2.24.

A number of equities analysts recently weighed in on IOSP shares. ValuEngine raised shares of Innospec from a “hold” rating to a “buy” rating in a research note on Thursday, November 9th. BidaskClub downgraded shares of Innospec from a “hold” rating to a “sell” rating in a research note on Friday, December 15th. Monness Crespi & Hardt downgraded shares of Innospec from a “buy” rating to a “neutral” rating in a research note on Thursday, November 9th. Johnson Rice raised shares of Innospec from a “hold” rating to an “accumulate” rating in a research note on Tuesday, November 14th. Finally, KeyCorp reissued an “overweight” rating on shares of Innospec in a research note on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $70.50.

In other Innospec news, insider Philip Curran sold 1,352 shares of the firm’s stock in a transaction on Friday, November 24th. The shares were sold at an average price of $71.05, for a total value of $96,059.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Milton C. Blackmore sold 977 shares of the firm’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $73.67, for a total transaction of $71,975.59. Following the completion of the sale, the director now owns 6,977 shares of the company’s stock, valued at $513,995.59. The disclosure for this sale can be found here. Insiders sold 24,366 shares of company stock valued at $1,743,891 over the last 90 days. Corporate insiders own 2.02% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Innospec (IOSP) to Release Quarterly Earnings on Tuesday” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.americanbankingnews.com/2018/02/06/innospec-iosp-to-release-quarterly-earnings-on-tuesday.html.

About Innospec

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Earnings History for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply